Posted inBiotechnology In-House 24-Hour Call Shifts Outdated in Modern Workplaces July 28, 2026 Hospitals have long relied on the 24-hour “in-house call”—a familiar feature of modern medical staffing in which physicians remain on-site…
Posted inBiotechnology Study Evaluates Interrater Reliability of the Bayley-4 in Multidisciplinary Teams July 28, 2026 A new study is shaking up how clinicians and researchers judge early childhood development tests by showing that results from…
Posted inBiotechnology Alcohol Intervention Proves Successful in Humanitarian Aid Setting July 28, 2026 A new randomized trial offers some of the strongest evidence yet that structured alcohol-reduction care can work in humanitarian settings…
Posted inBiotechnology Genes Influence Diet Choices and Metabolic Health, New Research Suggests July 28, 2026 National Harbor, Md. (July 27, 2026) — Some people seem naturally drawn to sweets and fatty foods, while others can…
Posted inBiotechnology Grant Funds Brain Imaging Research to Improve Post-Stroke Bladder Treatments July 28, 2026 Stroke-related urinary incontinence affects more than a third of survivors and often goes untreated at its neurological source. A new…
Posted inBiotechnology Study finds how sleep strengthens memory, and epilepsy disrupts the process July 28, 2026 Baltimore, July 27, 2026 — A new human study from researchers at the Kennedy Krieger Institute and Johns Hopkins Medicine…
Posted inBiotechnology Enzyme discovery may help clear deadly zombie cells from human tissues July 28, 2026 LA JOLLA (July 24, 2026)—As populations age worldwide, the key challenge is not just living longer but staying healthy longer.…
Posted inBiotechnology Incyte ditches phase 1-stage JAK inhibitor to pursue next-gen options July 28, 2026 Incyte has ditched a JAK2 inhibitor in phase 1 development for a rare blood cancer in favor of “next-generation” replacements.
Posted inBiotechnology Altimmune’s next-gen GLP-1 curbs heavy drinking in ‘unequivocal’ ph. 2 alcohol use disorder win July 28, 2026 An experimental drug targeting both GLP-1 and glucagon receptors has curbed heavy drinking in a phase 2 trial, providing hope…
Posted inBiotechnology Study Warns of Hidden Sleep Crisis Among Workers Over 50 July 28, 2026 Sleep problems may be far more widespread among mid-to-later life workers than clinicians and policymakers assumed, according to a year-long…